Careers Student Preparation Individual Clinical Experience AgreementVirtually all low-income programs such as food stamps, rental assistance and Medicare Extra Help, come with complex eligibility rules and income restrictions that are tied to a percentage of the federal poverty level, such as 100%, 135% or 150%. If your income is right on the borderline, and you get a high COLA boost, that could potentially cause you to see trims to benefits from programs that have income restrictions. Some individuals might lose access to certain low-income benefits altogether because the COLA boosts their income over the limit..How the Categories Compare Between the CPI-W and the CPI-E.Phasing in an increase in the payroll tax rate for workers and employers from 6.2% to 7.4% each over a period of twenty years. The gradual growth would mean an extra 50 cents in taxes per week each year for the average worker. … Continued
Health Time Is Right To Examine Delivery Of Long Term Services And Supports Magazine2020TSCL enthusiastically supports H.R. 1902, S. 915, H.R. 4841, and S. 1600, and we were pleased to see support grow for each of them this week. For more information, visit the Bill Tracking section of our website..In September, federal agents announced the arrests of 35 people linked to a huge genetic testing scam. Individuals charged are accused of billing Medicare for more than .1 billion worth of phony genetic tests. The crackdown included telemedicine companies, doctors, and labs which worked in an elaborate scheme that preyed on people's fears of having genetic markers for cancer..Now, as we draw close to the end of the year, the window for Congress to take major action to lower prescription drug prices is beginning to close. Concern is growing that the prospects of a substantial drug price reduction bill may get lost in the politics surrounding the 2020 election. Legislation that would allow Medicare to negotiate the cost of prescription drugs is in the House, and a bipartisan bill that would cap out-of-pocket Part D costs at ,100 a year is stalled in the Senate. The whole effort is fiercely being fought by the pharmaceutical industry, and the outcome remains unclear. … Continued